MedTrace Logo

EBV-associated Diffuse Large B Cell Lymphoma

NCT03378947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2019-02-22

No results posted yet for this study

Summary

The aim of this study is to characterize and compare clinical, pathological (histology, immunophenotype) and molecular features of EBV-related GZL and DLBCL: do they belong to the same entity or to two different subtypes of EBV-related lymphoma ?

Conditions

  • To Characterize and Compare Clinical, Pathological and Molecular Features

Interventions

OTHER

clinical and pathological data EBV-related GZL and DLBCL

Invesrigators will retrospectively collect clinical and pathological data of all EBV-related GZL and DLBCL in immunocompetent patients diagnosed in the pathology department Centre Hospitalier Lyon Sud. Investigators will analyze their clinical feature and prognosis.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-01-15
Completion
2018-11-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03378947 on ClinicalTrials.gov